Vivofectamine™ VF232 Liver LNP Composition in Ethanol
Vivofectamine™ VF232 Liver LNP Composition in Ethanol
Invitrogen™

Vivofectamine™ VF232 Liver LNP Composition in Ethanol

Vivofectamine VF232 Liver LNP Composition in Ethanol is a reagent for use in the creation of lipid nanoparticles (LNPs) for in vivo delivery of mRNA or mRNA/gRNA via intravenous (IV) route to the liver.
Have Questions?
Catalog number VF232LVCE
Price (KRW)/ 1 mL
Price:1,480
Your Price:
-
Add to cart
Price (KRW)/ 1 mL
Price:1,480
Add to cart
Vivofectamine™ VF232 Liver LNP Composition in Ethanol
Catalog numberVF232LVCE
Price (KRW)/ 1 mL
Price:1,480
-
Add to cart
Vivofectamine VF232 Liver LNP Composition in Ethanol is a reagent for use in the creation of lipid nanoparticles (LNPs) for in vivo delivery of mRNA or mRNA/gRNA via intravenous (IV) route to the liver. It can be used for various basic research applications such as protein expression, protein replacement, and genome editing.

Features and benefits

  • Optimized formulation for systemic liver delivery
  • Delivery efficiency data in vivo benchmarked to ionizable lipids used in leading clinical-stage or FDA-approved drugs
  • Safety characterization in vivo
  • Flexibility in choice of formulation device and method

Vivofectamine VF232 Liver LNP Composition in Ethanol is a pre-mixed solution with an optimized ratio of an ionizable lipid and helper lipids. It can be used with various formulation devices and methods.

Vivofectamine VF232 Liver LNP Composition in Ethanol is a Research Use Only reagent for use in basic research. For an LNP solution for drug development purposes with a path to clinical and commercial licensing and supply, please submit a contact us request at our Vivofectamine webpage to access our Vivofectamine Delivery Solutions Drug Developers Portfolio.

Vivofectamine VF232 Liver LNP Composition in Ethanol is an animal origin-free product.

For Research Use Only. Not for use in diagnostic procedures.
Specifications
ClassificationAnimal origin-free (AOF)
Delivery TypeIn vivo
FormatTube
Transfection TechniqueLipid-based Transfection, Lipid Nanoparticles, LNPs
SpeciesMouse
FormulationRatio-optimized mixture of lipid solution in ethanol
Product LineVivofectamine™
Product TypeReagent
Quantity1 mL
Shipping ConditionDry Ice
SterilityNon-sterile
TargetLiver
Sufficient ForEncapsulating up to 0.6 mg mRNA at N:P of 4 (yield is dependent on formulation process)
Unit Size1 mL